Metabolism and Target Organ Damage

Editor-in-Chief

Amedeo Lonardo

lonardoamedeo2@gmail.com

Operating Unit of Metabolic Syndrome, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy.

Research Interests: MAFLD, NAFLD, endocrine disorders, sex differences in NAFLD, metabolic syndrome, liver, hypobetalipoproteinemia, dysmetabolism in HCV infection, diabetes in cirrhosis
Special Issue:
Organ Dysfunction in Metabolic-Associated Fatty Liver Disease: Effect of Cofactors

Honorary Editors-in-Chief

Christopher D. Byrne

Professor of Endocrinology & Metabolism, Faculty of Medicine, University of Southampton, Southampton, UK.

Research Interests: liver lipid metabolism, endocrinology, dyslipidaemias, metabolic liver disease, type 2 diabetes, NAFLD
Contributions:
Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies
Giovanni Targher

Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

Research Interests: nonalcoholic fatty liver disease, type 2 diabetes, insulin resistance, metabolic syndrome, cardiovascular disease, chronic kidney disease
Contributions:
Precision medicine approaches in metabolic disorders and target organ damage: where are we now, and where are we going?

Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies
Special Issue:
Inter-relationships Between COVID-19 and Metabolic Disorders

Associate Editors

Luigi Elio Adinolfi

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Miraglia, Naples, Italy.

Research Interests: intrahepatic cholestasis, HCV cryoglobulinemia, chronic viral hepatitis, NAFLD, HCC
Pietro Andreone

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Research Interests: chronic hepatitis, cirrhosis, hepatocellular carcinoma, liver immunology, liver transplantation, liver stem cells
Contributions:
Liver transplantation and nonalcoholic steatohepatitis: the state of the art
Gyorgy Baffy

Department of Medicine, VA Boston Healthcare System and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Research Interests: nonalcoholic fatty liver disease, metabolic dysfunction-associated liver disease, steatohepatitis, portal hypertension, cirrhosis
Special Issue:
Mechanosignaling Pathways in Metabolic Dysfunction
Stefano Ballestri

Internal Medicine Unit, Department of Internal Medicine, Hospital of Pavullo, Modena, Italy.

Research Interests: NAFLD, metabolic syndrome, association between NAFLD and cardiovascular diseases, ultrasonography
Contributions:
Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies
Special Issue:
Hepatic Fibrosis and Cardiovascular Risk in Patients with Nonalcoholic Fatty Liver Disease
Stefano Bellentani

Consultant Gastroenterologist and Hepatologist, Italian Liver Foundation, Basovizza, Italy.

Research Interests: NAFLD, NASH, epidemiology, chronic viral hepatitis, irritable bowel syndrome, inflammatory bowel disease, metabolic disease
Contributions:
The Fatty liver Index (FLI) 15 years later: a reappraisal
Helena Cortez-Pinto

Vice-President of United European Gastroenterology (UEG); Professor of Hepatology, Faculdade de Medicina de Lisboa, Centro Hospitalar Lisboa Norte, Lisboa, Portugal.

Research Interests: NASH trials, metabolism, nutrition
Leonardo M. Fabbri

Member of Academia Europaea. Internal and Respiratory Medicine, Department of Morphology, Surgery and Experimental Medicine, Section of Respiratory Diseases, University of Ferrara, Ferrara, Italy.

Research Interests: respiratory diseases, metabolic medicine, endocrinology geriatrics, metabolism
Silvia R. Fargion

Department of Pathophysiology and Transplantation Ca' Granda IRCCS Foundation, Policlinico Hospital, University of Milan, Milan, Italy.

Research Interests: metabolic and virus liver diseases (MAFLD, NAFLD, HCV and HBV chronic hepatitis), vascular disorders in metabolic liver diseases, iron and copper induced liver diseases (hemochromatosis, Wilson disease)
Contributions:
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system
Giampiero Francica

Chief Diagnostic and Interventional Ultrasound Unit, Pineta Grande Hospital, Castel Volturno, Italy.

Research Interests: ultrasound, diagnostic, biopsy and ablation of liver tumors
Special Issue:
Metabolism and Cancer
Fulvio Lonardo

Department of Pathology, School of Medicine, Wayne State University, Detroit, MI, USA.

Research Interests: morphological, molecular, epidemiological, thoracic malignancies
Contributions:
Metabolism and cancer-select topics
Luca Roncucci

Department of Diagnostic and Clinical Medicine, and Public Health, University of Modena and Reggio Emilia, Modena, Italy.

Research Interests: colorectal carcinogenesis, hereditary colorectal cancer, inflammation, chemoprevention of tumors
Special Issue:
Metabolism and Cancer
Ayako Suzuki

Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA.

Research Interests: NAFLD, NASH, biological disparities, sex differences, gender differences, drug-induced liver injury, hepatotoxicity
Special Issue:
Sex Differences in Dysmetabolic Organ Damage and Senescence
Claudio Tiribelli

University of Trieste, Trieste, Italy; Scientific Director of the Italian Liver Foundation, Trieste, Italy.

Research Interests: fatty liver and associated diseases, liver damage, stem cells in HCC, personalized treatment, NAFLD
Contributions:
Novel high-throughput applications for NAFLD diagnostics and biomarker discovery

The Fatty liver Index (FLI) 15 years later: a reappraisal

Editorial Board Members

Annalisa Berzigotti

Head of Hepatology, University Clinic of Visceral Surgery and Medicine, Inselspital, University Hospital of Berne, Berne, Switzerland.

Research Interests: portal hypertension, non-invasive assessment of liver disease, obesity and liver disease
Águeda González-Rodríguez

Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM), Madrid, Spain.

Research Interests: liver, metabolism, NAFLD, fibrosis, insulin resistance, hepatocytes
Contributions:
Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus
Giovanni Guaraldi

Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Research Interests: HIV, immune-metabolism, NAFLF/MAFLD, lipodystrophy, aging, solid organ transplant, COVID-19
Youngmi Jung

Department of Biological Sciences, College of Natural Science, Pusan National University, Pusan, South Korea.

Research Interests: liver fibrosis, liver regeneration, stem cell therapy, cellular reprogramming, nonalcoholic fatty liver disease
Mariana Machado

Department of Gastroenterology and Hepatology, Hospital de Vila Franca de Xira, Lisbon, Portugal.

Research Interests: non-alcoholic/metabolic dysfunction-associated fatty liver disease, alcohol-associated liver disease, liver cirrhosis, end-stage liver disease, pathophysiology of liver disease
Contributions:
What should we advise MAFLD patients to eat and drink?

MAFLD under the lens: the role of gut microbiota
MariaLuz Martinez-Chantar

Liver Disease Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia, Spain.

Research Interests: liver disease, mechanism, metabolism, post-translational modifications, translational science
Chiara Mussi

Geriatrics, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Civil Hospital, Modena, Italy.

Research Interests: lipid-lowering drugs, osteoporotic, cardiology, atrial Fibrillation, dementia, older patients
Special Issue:
The Aging Cardio-metabolism: Can we Manage the Challenges of Becoming Oldest Old?
Laura E. Nagy

Department of Molecular Medicine, Case Western Reserve University, Cleveland, OH, USA.

Research Interests: alcohol-associated liver disease, macrophage biology, inflammation, cell death mechanisms, NAFLD/NASH
Contributions:
Diminished function of cytotoxic T- and NK- cells in severe alcohol-associated hepatitis
Sonia M. Najjar

Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.

Research Interests: insulin clearance, insulin metabolism, lipid metabolism, insulin resistance, inflammation, fibrosis, metabolic diseases, abdominal obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, atherosclerosis
Norbert Stefan

Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich, Tubingen, Germany.

Research Interests: pathophysiology of obesity and type 2 diabetes, pathophysiology and consequences of NAFLD, metabolically healthy obesity, hepatokines
Contributions:
Screening for advanced liver fibrosis in overweight and obese patients with NAFLD
Saula Vigili de Kreutzenberg

Department of Medicine, Division of Metabolic Diseases, University of Padova, Padova, Italy.

Research Interests: cardiovascular, NAFLD, type 2 diebetes, endocrinology, metabolic diseases
Wah Yang

Department of Metabolic and Bariatric Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Research Interests: metabolic and bariatric surgery, obesity, metabolic disorders
Contributions:
Laparoscopic Roux-en-Y gastric bypass for excess weight and diabetes: a multicenter retrospective cohort study in China
Special Issue:
Metabolic and Bariatric Surgery
Jin-Rong Zhou

Nutrition/Metabolism Laboratory, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Research Interests: nutrition, diet, metabolic disorders, cancer prevention

Hot Keywords

Editorial Board

Editor-in-Chief

Honorary Editors-in-Chief

Associate Editors

Editorial Board Members

Metabolism and Target Organ Damage

Navigation

follow us

OAE Publishing Inc.

OAE JOURNALS

FOLLOW OAE